InsiderGauge
Checking updates…
Dashboard

Wierenga Wendellinsider trades

In SEC Form 4 filings, Wierenga Wendell is listed as Director of Cytokinetics Inc (CYTK) and Director of Crinetics Pharmaceuticals, Inc. (CRNX). Wierenga Wendell reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 20.

Companies and roles

CompanyRoleTransactionsLast filed
CYTKCytokinetics IncDirector1Oct 20
CRNXCrinetics Pharmaceuticals, Inc.Director10Sep 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
CYTKCytokinetics IncOct 16Oct 20A97$63.92$6,20035,660NoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D116,146$85.00$9,872,4105,925NoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D5,925$85.00$503,625not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative12,500$61.76$772,000not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative12,500$61.77$772,125not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative17,500$64.77$1,133,475not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative17,500$66.71$1,167,425not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative17,500$64.68$1,131,900not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative12,500$40.29$503,625not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative10,350$52.67$545,135not reportedNoForm 4
CRNXCrinetics Pharmaceuticals, Inc.Sep 1Sep 1D · derivative9,730$49.13$478,035not reportedNoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.